Alendronate is a first-line therapy of postmenopausal women with osteoporosis in Slovenia

被引：0
|
作者：
Hren, R
Cokolic, M
机构：
[1] Univ Ljubljana, Ljubljana 1000, Slovenia
[2] Teaching Hosp Maribor, Maribor 2000, Slovenia
来源：
BONE | 2002年 / 30卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
B49
引用
收藏
页码：49S / 49S
页数：1
相关论文
共 50 条
  • [41] Treatment of osteoporosis in postmenopausal women: Alendronate vs intranasal calcitonin.
    Rosen, CJ
    Bonnick, SL
    Miller, PD
    McClune, M
    Wasnich, RD
    Weiss, SR
    Woodson, GC
    Schnitzer, TJ
    Lenihan, JP
    Ross, RP
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S399 - S399
  • [42] Comparison of raloxifene and alendronate on markers of cardiovascular health in postmenopausal women with osteoporosis
    Reginster, JY
    Adachi, JR
    Qu, Y
    Siddhanti, S
    Keech, C
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S42 - S42
  • [43] Patient compliance with alendronate, risedronate and raloxifene for the treatment of osteoporosis in postmenopausal women
    Ringe, J. D.
    Christodoulakos, G. E.
    Mellstroem, D.
    Petto, H.
    Nickelsen, T.
    Marin, F.
    Pavo, I.
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (11) : 2677 - 2687
  • [44] Comparative effectiveness of denosumab vs alendronate among postmenopausal women with osteoporosis
    Curtis, Jeffrey R.
    Arora, Tarun
    Liu, Ye
    Lin, Tzu-Chieh
    Spangler, Leslie
    Brunetti, Vanessa C.
    Stad, Robert Kees
    Mcdermott, Michele
    Bradbury, Brian D.
    Kim, Min
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 (07) : 826 - 834
  • [45] How could alendronate impact on postmenopausal women's lives with osteoporosis?
    Mir, E.
    Mirsafa, M.
    Hossein-Nezhad, A.
    Adibi, H.
    Larijani, B.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S115 - S116
  • [46] The effect of alendronate treatment on urinary calcium exretion in women with postmenopausal osteoporosis
    Ochodnicky, M
    Ochodnická, E
    Galajda, P
    Vladar, L
    Mokáñ, M
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S191 - S192
  • [47] Alendronate Vs intranasal calcitonin for treatment of osteoporosis in postmenopausal women.
    Downs, RW
    Favus, M
    Walsh, B
    Bell, NH
    Ettinger, MP
    Wang, L
    Mako, B
    Smith, ME
    Gormley, GJ
    Melton, ME
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S401 - S401
  • [48] Treatment of osteoporosis in postmenopausal women: Alendronate vs intranasal calcitonin.
    Schnitzer, TJ
    Rosen, CJ
    Bonnick, SL
    Miller, PD
    McClung, MR
    Wasnich, RD
    Weiss, SR
    Woodson, GC
    Lenihan, JP
    Ross, RP
    Wang, L
    Smith, ME
    Gormley, GJ
    Melton, ME
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S177 - S177
  • [49] Alendronate treatment decreases urinary calcium excretion in women with postmenopausal osteoporosis
    Ochodnicky, M
    Ochodnicky, B
    Ochodnicka, E
    Galajda, P
    Vladár, L
    Mokán, M
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S36 - S36
  • [50] Alendronate for the prevention of corticoid induced osteoporosis in postmenopausal women with polymyalgia rheumatica
    Sfoudouris, C
    Trifonidis, P
    Chilas, G
    Fragkakis, N
    Stamatiadou, A
    Lappa, B
    Karamitsiou, V
    Xatzhgiannhs, I
    Boudouris, K
    Georgiadis, AE
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S46 - S46
12345